Safety and Efficacy of the PAINLESS Nerve Growth Factor CHF6467 in Optic Pathway Glioma (OPG)

NCT05733572 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Optic Pathway Glioma

Interventions

DRUG: CHF6467
DRUG: Placebo

Sponsor

Benedetto Falsini